244 related articles for article (PubMed ID: 16585131)
1. Fluoroquinolone resistance and plasmid addiction systems: self-imposed selection pressure?
Ellington MJ; Woodford N
J Antimicrob Chemother; 2006 Jun; 57(6):1026-9. PubMed ID: 16585131
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of quinolone action and microbial response.
Hawkey PM
J Antimicrob Chemother; 2003 May; 51 Suppl 1():29-35. PubMed ID: 12702701
[TBL] [Abstract][Full Text] [Related]
3. Is plasmid-mediated quinolone resistance a clinically significant problem?
Poirel L; Cattoir V; Nordmann P
Clin Microbiol Infect; 2008 Apr; 14(4):295-7. PubMed ID: 18190576
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic resistance genes from the environment: a perspective through newly identified antibiotic resistance mechanisms in the clinical setting.
Cantón R
Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():20-5. PubMed ID: 19220348
[TBL] [Abstract][Full Text] [Related]
5. The changing epidemiology of resistance.
Hawkey PM; Jones AM
J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i3-10. PubMed ID: 19675017
[TBL] [Abstract][Full Text] [Related]
6. Role of a qnr-like gene in the intrinsic resistance of Enterococcus faecalis to fluoroquinolones.
Arsène S; Leclercq R
Antimicrob Agents Chemother; 2007 Sep; 51(9):3254-8. PubMed ID: 17620379
[TBL] [Abstract][Full Text] [Related]
7. Bacterial death comes full circle: targeting plasmid replication in drug-resistant bacteria.
DeNap JC; Hergenrother PJ
Org Biomol Chem; 2005 Mar; 3(6):959-66. PubMed ID: 15750634
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of plasmid-mediated fluoroquinolone resistance genes, qepA and qnrS1, in Enterobacter aerogenes co-producing RmtB and class A beta-lactamase LAP-1.
Park YJ; Yu JK; Kim SI; Lee K; Arakawa Y
Ann Clin Lab Sci; 2009; 39(1):55-9. PubMed ID: 19201742
[TBL] [Abstract][Full Text] [Related]
9. [Impact of fluoroquinolone use on multidrug-resistant bacteria emergence].
Nseir S; Ader F; Marquette CH; Durocher A
Pathol Biol (Paris); 2005; 53(8-9):470-5. PubMed ID: 16176863
[TBL] [Abstract][Full Text] [Related]
10. The worldwide emergence of plasmid-mediated quinolone resistance.
Robicsek A; Jacoby GA; Hooper DC
Lancet Infect Dis; 2006 Oct; 6(10):629-40. PubMed ID: 17008172
[TBL] [Abstract][Full Text] [Related]
11. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Romanian fluoroquinolone-resistant human clinical Escherichia coli isolates.
Usein CR; Tatu-Chiţoiu D; Nica M; Ciontea SA; Palade AM; Condei M; Damian M
Roum Arch Microbiol Immunol; 2008; 67(1-2):23-9. PubMed ID: 19284163
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
14. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
Preisler A; Heisig P
J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
[TBL] [Abstract][Full Text] [Related]
15. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
[TBL] [Abstract][Full Text] [Related]
16. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Yamane K; Wachino J; Suzuki S; Kimura K; Shibata N; Kato H; Shibayama K; Konda T; Arakawa Y
Antimicrob Agents Chemother; 2007 Sep; 51(9):3354-60. PubMed ID: 17548499
[TBL] [Abstract][Full Text] [Related]
17. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
Zheng J; Cui S; Meng J
J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
[TBL] [Abstract][Full Text] [Related]
18. Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure.
Yan M; Sahin O; Lin J; Zhang Q
J Antimicrob Chemother; 2006 Dec; 58(6):1154-9. PubMed ID: 17023497
[TBL] [Abstract][Full Text] [Related]
19. [Resistance to fluoroquinolone among Klebsiella spp strains producing extended-spectrum betalactamases isolated from urine].
Tlamçani Z; Ellaia K; Benomar A; Kabbaj H; Alaoui A; Seffar M
Ann Biol Clin (Paris); 2009; 67(5):553-6. PubMed ID: 19789127
[TBL] [Abstract][Full Text] [Related]
20. Emergence and maintenance of resistance to fluoroquinolones and coumarins in Staphylococcus aureus: predictions from in vitro studies.
Vickers AA; O'Neill AJ; Chopra I
J Antimicrob Chemother; 2007 Aug; 60(2):269-73. PubMed ID: 17556355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
